Concourse Financial Group Securities, Inc. Edgewise Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$11.42 - $20.13 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	BUY	$22.0 - $30.03 $0 - $0	0 New	0 $0
Q4 2024 Feb 13, 2025	BUY	$26.63 - $36.62 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$15.88 - $29.5 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$15.08 - $21.23 $0 - $0	0 New	0 $0

Q1 2024 Apr 30, 2024	BUY	$9.25 - $19.97 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$5.51 - $12.1 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$5.73 - $7.69 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$5.73 - $7.69 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$5.71 - $10.29 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$6.66 - $11.33 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$7.58 - $11.08 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$8.08 - $13.58 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$5.67 - $9.87 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$9.1 - $18.97 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$14.41 - $22.41 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$14.11 - $24.1 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$21.33 - $30.25 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$30.0 - $35.99 $0 - $0	0 New	0 $0

Others Institutions Holding EWTX

# of Institutions

186

Shares Held

112M

Call Options Held

188K

Put Options Held

121K

Orbimed Advisors LLC San Diego, CA

15.5M
Shares

$353 Million
8.59% of portfolio
Ra Capital Management, L.P. Boston, MA

10.4M
Shares

$237 Million
2.9% of portfolio
Baker Bros. Advisors LP New York, NY

7.31M
Shares

$166 Million
0.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

6.17M
Shares

$140 Million
3.22% of portfolio
Black Rock Inc. New York, NY

6.02M
Shares

$137 Million
0.0% of portfolio

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.44B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account